Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug ...
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
The main objective of this randomized, double-blind, placebo-controlled study was to measure the impact of a multivitamin supplement on nutrient status and quality of life (QOL) and compare two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback